Pivmecillinam
Sponsors
Uppsala Universitet, Odense University Hospital, Sykehuset i Vestfold HF, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Rigshospitalet, Denmark
Conditions
Antibiotic ProphylaxisBladder Cancer Requiring CystectomyBloodstream InfectionComplicated urinary tract infections (cUTI) requiring hospitalisationCystectomyFebrile Urinary Tract InfectionIleal ConduitKidney Transplant Infection
Phase 2
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized controlled non-inferiority multicenter trial
RecruitingCTIS2023-503447-33-00
Start: 2025-11-13Target: 560Updated: 2025-10-08
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Not yet recruitingNCT07407673
Start: 2027-01-01End: 2029-07-01Target: 150Updated: 2026-02-12
Phase 4
Treating Pyelonephritis an Urosepsis With Pivmecillinam
CompletedNCT03282006
Start: 2017-09-29End: 2020-04-21Updated: 2020-04-22
Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
CompletedNCT04959331
Start: 2021-11-02End: 2024-12-31Updated: 2025-09-08
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
RecruitingNCT06709196
Start: 2025-01-07End: 2027-01-31Target: 248Updated: 2025-01-09
Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
RecruitingNCT07236944
Start: 2025-12-31End: 2029-03-31Target: 560Updated: 2025-12-17
Evidence based empirical antibiotic treatment for urinary tract infections requiring hospitalisation - TRI-AB trial
Not yet recruitingCTIS2024-520251-24-00
Target: 618Updated: 2026-03-27